Venetoclax and Decitabine in Treating Participants With Relapsed/Refractory Acute Myeloid Leukemia or Relapsed High-Risk Myelodysplastic Syndrome
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Immune Oncology Research Institute
Dana-Farber Cancer Institute
Institute of Hematology and Blood Transfusion, Czech Republic
French Innovative Leukemia Organisation
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
Fred Hutchinson Cancer Center
Mayo Clinic
City of Hope Medical Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Therapeutic Advances in Childhood Leukemia Consortium
M.D. Anderson Cancer Center
Centre Hospitalier Universitaire de Besancon
Samsung Medical Center
Fred Hutchinson Cancer Center
Mayo Clinic
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center
Centre Hospitalier Universitaire de Besancon